Prognostic significance of blood clotting indicators for determination of the probability of developing the hemorrhagic syndrome in premature newborns with congenital pneumonia
https://doi.org/10.29235/1814-6023-2022-19-1-84-90
Abstract
One of the main complications of congenital pneumonia in premature newborns, leading to high mortality, is the development of hemorrhagic syndrome. Objective - to determine the prognostic significance of blood clotting indicators and the probability of developing hemorrhagic syndrome in premature newborns with congenital pneumonia.
The assessment of hemostasis indicators in 221 premature newborns who were treated and cared for in the State Institution RSPC “Mother and Child” in the period from 2017 to 2019 was carried out. A comparative analysis of the parameters of the coagulogram of the first day of life was performed with the allocation of the percentile range and the translation of absolute values into binary variables is made. Based on the results of the ROC analysis, a mathematical model was developed with a universal coefficient equal to χ2 = 24.19, p = 0.004, with a sensitivity of 92.9 % and an area under the ROC-curve AUC = 0.69 ± 0.039 (0.62-0.76), p < 0.001, and a computer support program for doctors. The prognostic significance of blood clotting parameters was calculated: activated partial thromboplastin time - 0.366, coefficient R - 0.208, prothrombin time - 0.321, prothrombin index according to Quick - 0.330, international normalized ratio - 0.242, thrombin time - 0.319, fibrinogen -0.295, D-dimer - 0.448, platelets - 0.478, which makes it possible to allocate premature newborns with congenital pneumonia with a threshold value of ≥0.293 to the risk group for the development of hemorrhagic syndrome.
About the Authors
A. N. HarachkaBelarus
Alexander N. Harachka - Ph. D. (Med.), Associate Professor, Belarusian State Medical University.
83, Dzerzhinski Ave., 220116, Minsk.
A. V. Sukalo
Belarus
Alexander V. Sukalo - Academician, D. Sc. (Med.), Professor, Head of the Department, Belarusian State Medical University.
83, Dzerzhinski Ave., 220116, Minsk.
References
1. Khanafer-Larocque I., Soraisham A., Stritzke A., Awad E., Thomas S., Murthy P., Kamaluddeen M., Scott J. N., Mohammad K. Intraventricular hemorrhage: risk factors and association with patent ductus arteriosus treatment in extremely preterm neonates. Frontiers in Pediatrics, 2019, vol. 7, art. 408. https://doi.org/10.3389/fped.2019.00408
2. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatric Research, 2010, vol. 67, no. 1, pp. 1-8. https://doi.org/10.1203/PDR.0b013e3181c1b176
3. Rebrova O. Y. Statistical analysis of medical data. Using the STATISTICA Application Package. Moscow, MediaSfera Publ., 2002. 312 p. (in Russian).
4. Petri A., Sabin C. Medical Statistics at a Glance. 3rd ed. Moscow, GEOTAR-Media Publ., 2015. 216 p. (in Russian).
5. Goryachko A. N., Sukalo A. V. Features of hemostasis in premature newborns with congenital pneumonia in the neonatal period. Zdorov'ya ditini [Children health], 2020, vol. 15, no. 7, pp. 510-517 (in Russian).
6. Volodin N. N. Children's diseases. Vol. 1. Neonatology. Moscow, Dinastiya Publ., 2011. 512 p. (in Russian).
7. Rooz R., Gentsel'-Borovicheni O., Prokitte G. Practical recommendations. Moscow, Meditsinskaya literatura Publ., 2011. 592 p. (in Russian).
8. Dmitriev V. V. Practical questions of clinical coagulology. Minsk, Belaruskaya navuka Publ., 2017. 278 p. (in Russian).
9. Zubovskaya E. T. Clinical and laboratory indicators (reference intervals): a guide for doctors. Minsk, Belarusian State University of Physical Education, 2009. 289 p. (in Russian).
10. Leonova E. Yu. Features of the hemostasis system in newborns. Okhrana materinstva i detstva [Protection of mothers and children], 2016, no. 2, pp. 76-81 (in Russian).
11. Zubovskaya E. T. System of hemostasis. Theoretical foundations and research methods. Minsk, Belarusian State University of Physical Education, 2009. 289 p. (in Russian).
12. Ols R. Hematology, immunology and infectious disease: neonatology questions and controversies. Moscow, Logosfera Publ., 2013. 408 p. (in Russian).
13. Ipema H. J. Use of oral vitamin K for prevention of late vitamin K deficiency bleeding in neonates when injectable vitamin K is not available. Annals of Pharmacotherapy, 2012, vol. 46, no. 6, pp. 879-883. https://doi.org/10.1345/aph.1q769
14. Kuz'menko G. N., Nazarov S. B., Chemodanov V. V. The state of hemostasis in premature newborns with respiratory distress syndrome. Ivanovo, Ivanovskii izdatel'skii dom Publ., 2016. 300 p. (in Russian).
Review
For citations:
Harachka A.N., Sukalo A.V. Prognostic significance of blood clotting indicators for determination of the probability of developing the hemorrhagic syndrome in premature newborns with congenital pneumonia. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2022;19(1):84-90. (In Russ.) https://doi.org/10.29235/1814-6023-2022-19-1-84-90